Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Budd-Chiari syndrome primary prevention
Introduction
Overview
Overview
Measures for the primary prevention of Budd-Chiari syndrome include effective management of predisposing conditions, chronic anticoagulation in patients with underlying hypercoagulable disorder, treat patients with an underlying myeloproliferative disorder with aspirin and hydroxyurea rather than anticoagulants such as warfarin.
Primary Prevention
Primary Prevention
Measures for the primary prevention of Budd-Chiari syndrome include:[1][2]
- Effective treatment of predisposing conditions
- Chronic anticoagulation in patients with underlying hypercoagulable disorder
- Treat patients with an underlying myeloproliferative disorder with aspirin and hydroxyurea rather than anticoagulants such as warfarin.
References
References
- ↑ Goel RM, Johnston EL, Patel KV, Wong T (2015). “Budd-Chiari syndrome: investigation, treatment and outcomes”. Postgrad Med J. 91 (1082): 692–7. doi:10.1136/postgradmedj-2015-133402. PMID 26494427.
- ↑ Darwish Murad S, Plessier A, Hernandez-Guerra M, Fabris F, Eapen CE, Bahr MJ, Trebicka J, Morard I, Lasser L, Heller J, Hadengue A, Langlet P, Miranda H, Primignani M, Elias E, Leebeek FW, Rosendaal FR, Garcia-Pagan JC, Valla DC, Janssen HL (2009). “Etiology, management, and outcome of the Budd-Chiari syndrome”. Ann. Intern. Med. 151 (3): 167–75. PMID 19652186.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mazia Fatima, MBBS [2]